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Purpose: To evaluate the levels of vitamin D in the serum of diabetic patients with and
without diabetic retinopathy (DR).
Methods: Thirty patients with DR and thirty diabetic patients without retinopathy were
included in this cross-sectional study. Based on ophthalmic examination, patients with
DR were categorized into having non-proliferative retinopathy (NPDR) and proliferative
retinopathy (PDR). Patients were tested for fasting blood sugar (FBS), hemoglobin A1C
(HbA1C), 25-hydroxy vitamin D (25 (OH) D), and creatinine levels in the serum, and for
urine protein. Vitamin D deficiency was defined as a serum 25 (OH) D level < 20 ng/mL.
Results: We found that all diabetic patients had mild vitamin D deficiency (serum 25 (OH)
D level = 10–20 ng/mL). Themean serum25 (OH) D concentration in patients with DRwas
lower than in those without DR (12.10 ± 14.62 ng/mL vs 15.61 ± 9.40 ng/mL, respectively,
P = 0.012). Trace or more proteinuria was frequently present in patients with DR than in
those without DR (56% in DR vs 30% in non-DR; P = 0.037). There were no significant
differences in the FBS, HbA1C, and serum creatinine levels between patients with or
without retinopathy.
Conclusion: The present study demonstrated that patients with DR had lower levels of
serum vitamin D compared with those without retinopathy.
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INTRODUCTION
The prevalence of diabetes mellitus, a metabolic
syndrome with several complications, has
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increased worldwide in the recent decades.[1]
Based on the latest global burden of disease
estimates in 2011 (SuRFNCD-2011), the prevalence
of type 2 diabetes in the Iranian population is 11%.[2]
Diabetic retinopathy (DR) is a major complication
of diabetes mellitus that can result in retinal
vascular abnormalities and severe visual
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impairment. DR is defined as a vascular disease
resulting from hyperglycemia, and is characterized
by altered structure of retinal endothelial vessels
and disrupted blood–retinal barrier. The retinal vas-
culature is gradually damaged resulting in ischemic
changes that lead to the formation of new vessels
and its consequences.[3]
Different studies have reported abnormalities in
the metabolism of calcium, phosphate, and vitamin
D in diabetic patients. Bayani et al showed that
vitamin D concentration was significantly lower in
diabetic patients compared with that in healthy
individuals.[4] Moreover, animal and human studies
have demonstrated a correlation between vitamin
D deficiency and impaired insulin production and
secretion as well as insulin sensitivity.[5–7] Another
study reported that reduced serum insulin levels
could be related to the lower level of 1,25(OH)2 D.[8]
Vitamin D has an inhibitory effect on vascu-
lar angiogenesis.[9] It is believed that vitamin D
deficiency, which is described as a serum 25
(OH) D concentration < 20 ng/mL, affects the
pathogenesis and progression of DR.[10]
Vitamin D deficiency is a common public health
concern. A study reports that the prevalence
of vitamin D deficiency varies across different
populations.[11] The prevalence of vitamin D defi-
ciency in the United States was reported to be
41.6% in 2005.[12] Additionally, individuals who had
no college education and had low serum levels
of high-density lipoprotein cholesterol, high body
mass index (BMI), hypertension or were on low cal-
cium diet had low serum vitamin D levels.[12] A study
in Tehran, Iran reported the prevalence of vitamin
D deficiency to be 43.3% among adolescents, with
higher rates in females compared to males.[13]
The most likely crucial role of Vitamin D related
to diabetic pathogenicity and its main complica-
tions such as DR is its involvement in several
body mechanisms such as adjustment of blood
glucose or body vascular consistency. Therefore,
we decided to investigate the serum levels of
vitamin D in our diabetic patients with and without
DR in Fars Province, Iran.
METHODS
This cross-sectional study was conducted on
patients with type 2 diabetes who were referred to
the ophthalmology clinics of the Shiraz University
of Medical Sciences. The study was approved
by the Shiraz University of Medical Sciences
Ethics Committee. Thirty patients with DR and
thirty patients without retinopathy were included.
Patients with a history of smoking, chronic kidney
disease, active infection, liver disease, primary or
secondary hyperparathyroidism, serum creatinine
levels > 2 mg/dL, and those receiving vitamin
D, calcium supplements, or any other medication
that could change vitamin D metabolism, such as
rifampin or phenytoin, were excluded from the
study. Patients who had a history of bone fracture
or orthopedic surgeries during the past year were
also excluded.
Age, sex, and duration of diabetes were
recorded for all subjects. Patients were categorized
into two groups based on the duration of diabetes
(< 10 years and > 10 years).
All patients underwent complete ophthalmic
examination by a vitreoretinal surgeon for diagnos-
ing DR; this examination consisted of funduscopy
with a slit-lamp and 90 D lenses and an indirect
ophthalmoscopy. DR was diagnosed in the pres-
ence of one or more of the following signs: microa-
neurysms, cotton-wool spots, intraretinal hemor-
rhages, ormacular edema. DRwas categorized into
mild to severe non-proliferative diabetic retinopa-
thy (NPDR) based on the absence of any neo-
vascularization and proliferative diabetic retinopa-
thy (PDR). Mild NPDR was defined as having
only microaneurysms, whereas severe NPDR was
defined as having any one of the following features:
severe intraretinal hemorrhages in four quadrants,
venous beading in two or more quadrants and
intraretinal microvascular anomalies (IRMAs) in one
or more quadrants; moderate NPDR was between
the above two categories. In cases of asymmetrical
retinopathy, the patient was assigned to the group
corresponding to the eye with the more severe
retinopathy scale.
Blood samples were drawn in the morning after
a 12-h fast. Fasting blood sugar (FBS) and glycated
hemoglobin A1C (HbA1C) and serum calcium, phos-
phorus, and creatinine levels were measured. The
presence of protein in the urine was checked with
dipstick method.
Serum vitamin D level was assessed measuring
the level of serum 25-OH vitamin D. The 25
(OH) D levels were measured from serum samples
using solid phase enzyme-linked immunosorbent
assay (DRG 25 (OH) D total ELISA Kit; DRG Instru-
ments GMBH, Germany). The serum concentration
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> 30 ng/mL was considered as sufficient. Cut-
offs for serum vitamin D concentration status are
described in Table 1.
Statistical Analysis
SPSS 17.0 software for Windows (SPSS Inc.,
Chicago, IL, USA) was used for data analysis. The
variables with a normal distribution are shown as
mean ± standard deviation, and nominal variables
are expressed as number and percentage. The
normality assumption in continuous variables was
evaluated using the Kolmogorov–Smirnov test.
Distributions higher than P > 0.05 were accepted
as normally distributed variables. The differences
between normally distributed and continuous inde-
pendent variables were assessed by the indepen-
dent samples t-test. Those without a normal dis-
tribution were compared using the Mann–Whitney
U test between the groups. Categorical variables
were compared using the Chi-squared test. For all
comparisons, P < 0.05 was considered significant.
RESULTS
The study included 15 female subjects with mean
age (± standard deviation) of 60.13 ± 6.02 years
and 15 males with mean age of 57.60 ± 5.43
years in the group with DR and 16 females with
mean age of 59.05 ± 6.25 years and 14 males
with mean age of 57.30 ± 8.50 years in the group
without DR. There was no statistically significant
difference between the groups regarding their age
(P = 0.73) and sex (P = 0.75).
The demographic and clinical characteristics of
the patients in the study are shown in Table 2.
Among patients with DR, 21 patients had NPDR
(13 mild to moderate and 8 severe) and 9 patients
had PDR. All patients had mild vitamin D defi-
ciency. The mean serum vitamin D concentration
in patients with DR (12.10 ± 14.62 ng/mL; NPDR and
PDR) was lower than in those without DR (15.61 ±
9.40 ng/mL) (P = 0.012). Regression analysis with
independent variables (FBS, duration of diabetes
and insulin use) showed similar results (P = 0.031).
The mean 25 (OH) D concentration between the
DR subgroups (severe NPDR and PDR vs mild to
moderateNPDR)was 10.51± 10.45 ng/mL and 13.45
± 8.4 ng/mL, respectively (P = 0.681).
Serum 25 (OH) D concentration in all patients
was compared among the age groups. Themean±
SD in patients with age ranging from 41 to 50 years,
51 to 60 years, and ≥ 60 years were 10.11 ± 9.50,
14.15 ± 16.06, 14.99 ± 6.94, respectively (P = 0.128).
Regarding the treatment, 46%of patientswithout
DR and 86.6% of patients with DR were taking
insulin. Univariate analysis between the two groups
showed that the use of insulin in patients with DR
was significantly higher than in those without DR (P
= 0.014).
The duration of diabetes was different between
the groups. Nine (30%) patients with no diabetic
retinopathy (NDR) had diabetes for more than 10
years and 16 (53%) patients with DR had diabetes
for more than 10 years. However, the difference
was not statistically significant (P = 0.081).
Binomial variable multiple logistic regression
analysis with independent variables revealed that
FBS, HbA1C, BUN, serum creatinine, and serum
vitamin D levels did not show the duration of
diabetes as an independent risk factor for DR (P =
0.067). However, this value was significant in terms
of the type of treatment (insulin use or not) (P =
0.005).
Patients with DR had a higher positive dipstick
test rate for proteinuria than those without DR (56%
of the patients with DR had traces of or more
proteinuria vs 30% in no DR; P = 0.037).
FBS, serum BUN, and creatinine levels were
not different between the patients with or without
retinopathy. Although vitamin D may influence the
levels of serum calcium, our data showed no sig-
nificant difference in serum calcium or phosphorus
between the two groups (P = 0.511 and P = 0.416,
respectively).
DISCUSSION
In the current study, we evaluated the serum levels
of vitamin D in diabetic patients with and without
DR. Furthermore, we investigated other possible
factors that could influence the progression of DR.
Similar to previous studies, all included patients
had 25 (OH) D deficiency.[15–17] The current study
showed that the mean serum 25 (OH) D concen-
tration in patients with DR was lower than in those
without DR, especially thosewith severe NPDR and
PDR. These results were comparable to other stud-
ies. For example, Payne et al found that diabetic
patients, especially those with PDR, had lower 25
(OH) D levels than those without diabetes.[19] Sim-
ilarly, Luo et al in their meta-analysis that included
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Table 1. Serum 25(OH) D concentration[14]
25(OH) D concentration 25(OH) D status
≤ 10 ng/mL Severe deficiency
10–20 ng/mL Mild deficiency
20–30 ng/mL Insufficient
30 ≤ ng/mL Adequate
100 ≤ ng/mL Potential toxicity
Table 2. Demographic and clinical characteristics of patients
Patients with no DR Patients with DR P-value
Gender (female/male), n 16/14 15/15 0.73
Age (years), mean ± SD 58.30 ± 7.23 58.57 ± 5.78 0.75
FBS (mg/dL), mean ± SD 146.43 ± 58.91 164.37 ± 88.98 0.54
HbA1c (%), mean ± SD 7.18 ± 1.58 7.90 ± 2.25 0.45
Hb (g/dL), mean ± SD 14.20 ± 1.22 13.48 ± 2.04 0.78
BUN (mg/dL), mean ± SD 13.66 ± 3.98 17.03 ± 7.40 0.41
Cr (mg/dL), mean ± SD 1.02 ± 0.25 1.21 ± 0.72 0.33
Calcium (mg/dL), mean ± SD 9.26 ± 0.45 8.92 ± 0.48 0.511
Phosphorus (mg/dL), mean ± SD 3.75 ± 0.42 3.66 ± 0.50 0.416
25-OH D (ng/mL) mean ± SD 15.61 ± 9.40 12.10 ± 14.62 0.012
BUN, blood urea nitrogen; Cr, creatinine; DR, diabetic retinopathy; FBS, fasting blood sugar; HbA1c, hemoglobin A1c; Hb,
hemoglobin; SD, standard deviation.
eight studies involving 13,435 participants showed
vitamin D deficiency (serum 25 (OH) D levels < 20
ng/mL) increased the risk of DR (OR = 2.03, 95% CI:
1.07–3.86)[20] On the contrary, some studies found
no differences in serum vitamin D levels between
diabetic patients with and without retinopathy.[16, 18]
Evidence shows that vitamin D may affect the
pathogenesis of DR via its effects on angio-
genesis by changing the presence of hypoxia-
inducible products, such as vascular endothelial
growth factor (VEGF).[9] Ben-Shoshan et al found
that 1, 25 (OH)2D3 decreases the protein expres-
sion of both regulated hypoxia-inducible factor
(HIF)-1α subunit and the VEGF in human cancer
cells.[21] Vitamin D reduces inflammatory prod-
ucts by decreasing the lymphocyte proliferation
and cytokine production.[22] Moreover, vitamin D
deficiency influences the activity of tissue matrix
metalloproteinase (MMPs) and C-reactive protein
(CRP) that are involved in microangiopathies.[23]
We demonstrated that DR occurred more fre-
quently in patients who were on insulin therapy
than in those who used oral hypoglycemic agents
to control their blood sugar (P = 0.005). This could
be attributed to low vitamin D concentration in
these patients that could disturb the regulation of
internal insulin secretion and increase the need for
external insulin to control the blood sugar.[7, 8] In the
present study, there were no statistically significant
differences between groups regarding their HbA1c,
FBS, and the duration of diabetes. Furthermore,
patients with DR had higher proteinuria than those
without, which could demonstrate a correlation
between DR and nephropathy.
Multiple studies reported that the presence of
DR in type 2 diabetic patients was associated with
longer duration of diabetes and higher levels of
HbA1c.[24–26] However, in the present study, such
correlation was not found; this disagreement could
be explained by the small sample size of the
current study that was not sufficient to detect these
associations.
The cross-sectional design and the small sample
size are the limitations of our study. Furthermore,
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outdoor activity time, patients’ daily diet, and the
mean blood pressure of patients, which are known
to affect vitamin D levels,[27] were not considered in
the study.
Although there are several published studies
on this topic with different results, to the best
of our knowledge, no study on this subject is
available from Fars Province, Iran. To improve our
understanding of vitamin D deficiency and DR, a
larger population-based study is required.
In conclusion, the current study showed that
patients with type 2 diabetes and DR had lower
serum vitamin D levels than those without DR.
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